Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN2A | Q99250 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | STAT6 | P42226 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15577172 | 0.81 | ERCC1 (0.55) | MEN1KMT2AALDH1A1POLBALOX15 | |
| SCHEMBL29025238 | 0.79 | SCN2A (0.44) | SCN2AMEN1KMT2AALDH1A1HTT | |
| SCHEMBL27582192 | 0.77 | CES1 (0.53) | ALDH1A1HTTTP53BCHECES1 | |
| SCHEMBL13619924 | 0.76 | POLB (0.42) | SCN2AKMT2AALDH1A1HTTPOLB | |
| SCHEMBL11665539 | 0.73 | EHMT2 (0.45) | SCN2AMEN1KMT2AALDH1A1POLB | |
| SCHEMBL10620767 | 0.71 | SCN2A (0.46) | SCN2AMEN1KMT2ACTDSP1ALDH1A1 | |
| SCHEMBL10620771 | 0.71 | SCN2A (0.46) | SCN2AMEN1KMT2ACTDSP1ALDH1A1 | |
| Nitric Acid SCHEMBL11839157 | 0.71 | CASP3 (0.61) | SCN2AMEN1KMT2AALDH1A1HTT | |
| SCHEMBL768174 | 0.71 | CYP1A2 (0.48) | SCN2AMEN1KMT2ACTDSP1ALDH1A1 | |
| SCHEMBL8115118 | 0.71 | SCN2A (0.46) | SCN2AMEN1KMT2ACTDSP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119285608-A | Preparation method of chiral 6-amino nicotine | 恒信永基科技(深圳)有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-119076058-A | Carbon intercalation iron phthalocyanine heterogeneous junction and preparation method and application thereof | 南京大学 | 2024-12-06 | — | — | CN | claimed |
| EP-3397635-B1 | METHODS FOR THE MANUFACTURE OF AN AROMATIC BISIMIDE AND A POLYETHERIMIDE | SHPP GLOBAL TECH BV (NL) | 2021-11-03 | — | — | EP | claimed |
| US-20210206747-A1 | METHODS FOR THE MANUFACTURE OF AN AROMATIC BISIMIDE AND A POLYETHERIMIDE | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2021-07-08 | — | — | US | claimed |
| CN-107903203-B | Synthetic method of 3, 4-dinitrophthalimide | 五邑大学 | 2020-06-19 | — | — | CN | claimed |
| EP-3397635-A1 | METHODS FOR THE MANUFACTURE OF AN AROMATIC BISIMIDE AND A POLYETHERIMIDE | SABIC Global Technologies B.V. (NL) | 2018-11-07 | — | — | EP | claimed |
| CN-108587074-A | High-melting-point electronic material | 太仓双赢电子电气成套设备有限公司 | 2018-09-28 | — | — | CN | claimed |
| CN-107903203-A | A kind of synthetic method of 3,4 pairs of nitrophthalimides | 五邑大学 | 2018-04-13 | — | — | CN | claimed |
| WO-2017117449-A1 | METHODS FOR THE MANUFACTURE OF AN AROMATIC BISIMIDE AND A POLYETHERIMIDE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-07-06 | — | — | WO | claimed |
| CN-106905914-A | A kind of semi-intercrossing network polyimide resin composition and its membranaceous adhesive of preparation | 成都正威新材料研发有限公司 | 2017-06-30 | — | — | CN | claimed |
| US-4933469-A | Method for preparing oxybisphthalimides | GENERAL ELECTRIC COMPANY (US) | 1990-06-12 | — | — | US | claimed |
| US-4780544-A | HEATING N-ORGANONITROPHTHALIMIDE IN PRESENCE OF APROTIC SOLVENT IN ALKALI METAL CARBOXYLATE | GENERAL ELECTRIC COMPANY (US) | 1988-10-25 | — | — | US | claimed |
| EP-0250981-A2 | Method for making bisimides | GENERAL ELECTRIC COMPANY (US) | 1988-01-07 | — | — | EP | claimed |
| US-4455431-A | Method for making bis-etherphthalimides | GENERAL ELECTRIC COMPANY (US) | 1984-06-19 | — | — | US | claimed |
| US-4054577-A | Preparation of aromatic bisimides | GENERAL ELECTRIC COMPANY (US) | 1977-10-18 | — | — | US | claimed |
| US-4020069-A | FROM BISPHENOL A AND A NITRO-PHTHALIMIDE, HYDROLYSIS | GENERAL ELECTRIC COMPANY (US) | 1977-04-26 | — | — | US | claimed |
| US-4017511-A | Preparation of aromatic bisimides | GENERAL ELECTRIC COMPANY (US) | 1977-04-12 | — | — | US | claimed |
| US-3992406-A | Preparation of aromatic bisimides | GENERAL ELECTRIC COMPANY (US) | 1976-11-16 | — | — | US | claimed |
| US-3957862-A | FROM A NITRO-PHTHALIMIDE AND ALKALI DIPHENOXIDE | GENERAL ELECTRIC COMPANY (US) | 1976-05-18 | — | — | US | claimed |
| US-3933852-A | Process for making N-methyl nitrophthalimides | GENERAL ELECTRIC COMPANY (US) | 1976-01-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210206747-A1 | METHODS FOR THE MANUFACTURE OF AN AROMATIC BISIMIDE AND A POLYETHERIMIDE | PAH, DDC, TNNI3K | SCN2A 655/4885MEN1 1389/4885KMT2A 938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.